Participants list

Industries
Abbott Bioresearch Center, USA
Abbott Laboratories, USA
ActivX Biosciences, USA
ADV Bioscience LLC, USA
AstraZeneca, UK
Biogen Idec, Inc., USA
BioPerspectives, USA
Boehringer Ingelheim Pharma GmbH, Germany
Boryung Pharmaceutical Company, Korea
Bruker daltonik GmbH, Germany
Cangen Biotechnologies, USA
Cellzome AG, USA
Centocor R&D Inc., USA
CSIRO Molecular & Health Technologies, Australia
DSM Biologics Company BV, The Netherlands
Eprogen, Inc., USA
Eureka Therapeutics Inc., USA
F. Hoffmann-La Roche, Switzerland
Fluorotronics, Inc., USA
FOGALE Nanotech, France
GE Global Research Center, USA
Genetix, UK.
GenScript Corporation, USA
Genzyme, Switzerland
Hoffmann-LaRoche Inc., USA
HTL Biosolutions Inc., USA.
JENEIL BioProducts GmbH, Germany
Kyorin Pharmaceutical Co., LTD., USA
Lectus Therapeutics Ltd, UK
Life Technologies, USA
Medarex Inc., USA
Medicinal Chemistry, UCB, UK
MedImmune LLC, USA
Merck & Co., Inc., USA
Millipore Corporation, USA
Nerviano Medical Sciences, Italy
NeuroDrug Consulting, USA
Novartis, China
Novozymes A/S, Denmark
PamGene BV, The Netherlands
Pfizer Global Research and Development, USA
Pharmadiscover Inc., China
Prolexys Pharmaceuticals, USA
Rainbow Bioscience, LLC, USA
Sanofi Pasteur, France
Seattle Genetics, USA
Sigma-Aldrich Biotechnology, USA
Sundia MediTech Company, Ltd., China
SuppreMol GmbH, Germany
Trellis Bioscience, USA
Vitae Pharmaceuticals Inc., USA
Vybion,Inc., USA
Wyeth Research, USA

Academia

Advanced Science Institute, Japan
Agricultural Research Council( CRA ), Italy
AIIMS, India
AIST Tokyo Waterfront, Japan
Biotechnology Research Institute, Canada
Boston University School of Medicine, USA
Brussels Center for Redox Biology, Belgium
Butler University, USA
Cardiff University, UK
Case Western Reserve University School of Medicine, USA
Cell Surface Signalling Laboratory, UK
Centinela Freeman Memorial Hospital, USA
Central Division of Analytical Chemistry, Germany
Chemistry RAMS, Russia
Children's Hospital of Orange County, USA
Clinical Proteomics Center, Taiwan
Consortium for Genomic Technologies, Italy
Cornell University, USA
Craig Venter Institute, USA
Dalhousie University, Canada
Department of Chemistry, University of Ioannina, Greece
Eindhoven University of Technology, The Netherlands
Erasmus Medical Center, Netherlands
ETH Zurich, Switzerland
Federal University of Rio de Janeiro, Brazil
Florida State University, USA
Fox Chase Cancer Center, USA
Fred Hutchinson Cancer Research Center, USA
Georgia Institute of Technology, USA
Goethe University, Germany
Hannam University, Korea
Harvard University, USA
HELIOS Klinikum Berlin-Buch and Experimental and Clinical Research Center, Germany
Hiroshima University, Japan
Hungarian Academy of Sciences, Hungary
Ibaraki University, Japan
Idaho State University, USA
Indiana University, USA
Institut de Pharmacologie Moléculaire et Cellulaire, France
Institut Pasteur de Lille, France
Institute for Biology and Chemistry of Proteins, France
Institute of Mechanics Bulgarian Academy of Sciences, Bulgaria
Institute of Microbial Technology, India
Institute of Molecular Biology and Biological Physics, USA
Iwate medical University, Japan
Jamia Millia Islamia(Central University), India
Johns Hopkins Hospital, USA
Johns Hopkins University School of Medicine, USA
Joseph Fourrier University, France
Karolinska University Hospital, Sweden
Katholieke Universiteit, Belgium
King Saud University, Kingdom of Saudi Arabia
Kyoto University, Japan
Kyungpook National University, Korea
Liver Research Center & Department of Hepato-Gastroenterology, Taiwan
London Research Institute, UK
M. D. Anderson Cancer Center, USA
Masaryk University, Czech Republic
Max-Planck Institute of Molecular Physiology, Germany
McGill University, Canada
McMaster University, Canada
Middle East Technical University, Turkey
Midwestern University, USA
MIT, USA
Moffitt Cancer Center & Research Institute, USA
Monash University, Australia
Mount Sinai School of Medicine, USA
Nara Institute of Science and Technology, Japan
Nara Women's University, Japan
National Institutes of Health, USA
National University of Singapore, Singapore
Newcastle University, UK
Northwest A & F University, China
Osaka University, Japan
oungnam University, Korea
Padmashree Dr. D.Y. Patil University, India
Princeton University, USA
Proteomics International, Australia
PSG College of Pharmacy, India
Rensselaer Polyechnic Institute, USA
Rice University, USA
Second Affiliated Hospital of Soochow University, China
Sejong University, Korea
Seoul National University, Korea
St. Jude Children's Research Hospital, USA
Stanford University, USA
State University of New York, USA
Stony Brook University, USA
Stowers Institute for Medical Research, USA
The Chinese University of Hong Kong, China
The Hebrew University of Jerusalem, Israel
The Italian Institute of Technology, Italy
The Ohio State University, USA
The University of Adelaide, Australia
The University of Iowa, USA
The University of Kansas, USA
The University of Melbourne, Australia
The University of North Carolina at Chapel Hill, USA
The University of Tokyo, Japan
The University of Texas M.D. Anderson Cancer Center, USA
Tohoku University, Japan
United States Department of Agriculture, USA
Universidad Nacional Autnoma de Mxico, Mexico City
Universita degli studi di pavia, Italy
Université de Montréal, Canada
Universite de Sherbrooke, Canada
Université Paris, France
Université Rennes, France
University College London, UK
University Graz, Austria
University in Innsbruck, Austria
University of Bristol, UK
University of California, USA
University of Chicago, USA
University of Chicago, USA
University of Cincinnati, USA
University of Erlangen-Nuremberg, Germany
University of Florida College of Medicine, USA
University of Haifa, Israel
University of Heidelberg, Germany
University of Hong Kong, China
University of Illinois, USA
University of Ioannina, Greece
University of Leeds, UK
University of Leeds, UK
University of Liverpool Cancer Research Centre, UK
University of Malaya centre for Proteomics research, Malaysia
University of Medical Sciences, Iran
University of Melbourne, Australia
University of Michigan, USA
University of Minnesota, USA
University of Mississippi Medical Center, USA
University of Miyazaki, Japan
University of Montreal, Canada
University of Munich, Germany
University of North Carolina at Chapel Hill, USA
University of North Carolina, USA
University of Oslo, Norway
University of Otago, Christchurch Cardioendocrine Research Group, New Zealand
University of Oulu, Finland
University of Oulu, Finland
University of Pennsylvania, USA
University of Pittsburgh Drug Discovery Institute, USA
University of Pittsburgh School of Medicine, USA
University of Pittsburgh, USA
University of Portsmouth, UK
University of Rochester School of Medicine and Dentistry, USA
University of Science and Technology of Lille, France
University of South Australia, Australia
University of Stuttgart, Germany
University of Tartu, Estonia
University of Texas Medical Branch, USA
University of Texas, USA
University of Tokyo, Japan
University of Toronto, Canada
University of Virginia, USA
University of Washington, USA
University of Waterloo, Canada
University of Western Ontario, Canada
University of Western Sydney, Australia
University of Zagreb, Croatia
University of Zürich, Switzerland
University of California, USA
University of Houston, USA
University of Illinois College of Medicine, USA
University of Massachusetts Medical School, USA
University of Pittsburgh School of Medicine, USA
Uppsala University, Sweden
Vanderbilt University Medical Center, USA
Vanderbilt University, USA
Walter and Eliza Hall Institute of Medical Research, Australia
Weill Medical College of Cornell University, USA
Yale University School of Medicine, USA
Yale University, USA
Yokohama National University, Japan
Yonsei University, Korea
Youngnam University, Korea


Schedule

Program Schedule
Time: March 21-23, 2010
Venue: 3F, Beijing International Convention Center (BICC), Beijing, China
Beijing Continental Grand Hotel (BCGH), Beijing, China


Date

Time

Program

Place

March 20, 2010

08:00-20:00

Registration

3F,BICC

Morning
March 21, 2010

08:00-08:30

Group Photo

3F, BICC

09:00-09:30

Opening Ceremony

No.3 Meeting Room, 1F, BICC

09:30-11:45

Keynote Forum

March 21, 2010

12:00-13:00

Luncheon

Banquet Hall, 2F, BCGH

Afternoon
March 21, 2010

13:30- 17:30

S1-1:Advances of Protein Molecular Biology and Cell Biology

301, 3F,BICC

13:30- 17:30

S1-2:Protein Folding Dynamics, Stability and Quality Control

309, 3F,BICC

13:30-15:30

S2-1:Protein Screening, Bioassay and Discovery

302, 3F,BICC

15:30-17:30

S2-2:Protein Chips, Arrays and Protein Structures in Silico

13:30-17:30

S3-1:Protein Interactions and Diseases

303, 3F,BICC

16:10-17:30

S3-2:Protein Networks in Disease

305A, 3F,BICC

13:30-16:10

S4-1:MS, Imaging MS and MALDI-TOF in Proteomics

305A, 3F,BICC

13:30- 14:50

S5-1:Protein Kinases and Kinome as Drug Targets-Preclinical to Clinical Trials

310, 3F,BICC

14:50- 17:30

S5-2:Protein Kinase and Apoptosis

13:30-14:50

S6-1:Target Discovery and Validations

311A, 3F,BICC

14:50-17:30

S6-2:GPCRs in Drug Discovery

13:30-15:30

S7-1:Advances in Control of Gene Expression and Alternative Expression

311B, 3F,BICC

15:30-17:30

S7-2:Eukaryotic/ Prokaryotic, Insect and Mammalian Expression

13:30-15:30

S9-1:Protein Design and Evolution for Enzymes

311C, 3F,BICC

15:30-17:30

S9-2:Protein Biomaterial Design and Implications

13:30-17:30

S11-1:Cell Line Engineering and Development

306, 3F,BICC

March 21, 2010

18:00-20:00

Welcome Banquet

Banquet Hall, 2F, BCGH

Morning
March 22, 2010

08:30-12:10

S1-3:Protein-Protein Interactions and Protein-Transduction

301, 3F,BICC

08:30-12:10

S1-4:Proteins Interacting with DNA and RNA

311C, 3F,BICC

08:30-12:10

S2-3:NMR, EM and X-Ray Crystallography

302, 3F,BICC

08:30-10:55

S3-3:Proteins in Apoptosis and Autophagy

303, 3F,BICC

10:55-12:15

S3-4:Protein Misfolding and Cancers

08:30-10:30

S4-2:Computational Proteomics and Bioinformatics

305A, 3F,BICC

10:30-12:10

S4-3:Nanoproteomics, Chip and Array Technologies in Proteomics

08:30-10:30

S5-3:Protein Kinase Inhibitors in Cancer

311B, 3F,BICC

08:30-12:10

S5-4:Protein Kinase and Cell Cycle Control

310, 3F,BICC

08:30-09:50

S6-3:Protein Structure, Modeling, and Fragment-Based Drug Discovery

311A, 3F,BICC

09:50-12:10

S6-4:Transmembrane Peptides as Novel Therapeutics

10:30-12:15

S7-3:Novel Protein Expression Systems and Sample Purification, Detection Technologies

311B, 3F,BICC

08:30-10:55

S11-2:Improved Separation, Purification, Recovery, Crystallization, and Lyophilization

306, 3F,BICC

10:30-12:10

S11-3:Scaling Up Bioprocess Development for Biotherapeutics

March 22, 2010

12:00-13:00

Luncheon

Banquet Hall, 2F, BCGH

Afternoon
March 22, 2010

 

13:30-17:30

S1-5:Structure Biology, Protein Structure, Dynamics and Functions (Part I)

301, 3F,BICC

13:30-15:50

S2-4:Cell Free Technologies for Proteins

302, 3F,BICC

15:50-17:30

S2-5:Protein Separation and Purification Technologies

13:30-17:30

S3-5:Protein Misfolding and Neurodegeneration

303, 3F,BICC

13:30-17:30

S4-4:Proteome Technologies and Breast Cancer, Colorectal and Colon Cancer

305A, 3F,BICC

13:30-17:30

S5-5:Receptor Tyrosine Kinases

310, 3F,BICC

13:30-17:30

S5-6:The EGF Receptor and Associated Signaling

311B, 3F,BICC

13:30-15:55

S6-5:Protein Drug Delivery System and Nanotechnologies

311A, 3F,BICC

15:55-17:30

S6-6:Design Drugs Targeting Protein-Protein Interactions

13:30-15:30

S10-1:Progress of Analytical Techniques for Protein

311C, 3F,BICC

15:30-17:30

S10-2:Chip and Array Technology for Protein Analysis

13:30-15:30

S11-4:Cell Culture and Up- Stream Process Development

306, 3F,BICC

15:30-17:30

S11-5:New Protein Therapeutic Formulation Development

March 22, 2010

18:00-19:00

Dinner

Banquet Hall, 2F, BCGH

Morning
March 23, 2010

08:30-12:10

S1-6:Membrane Proteins

301, 3F,BICC

08:30-12:10

 S1-7:Proteins and Signaling

302, 3F,BICC

08:30-11:10

S1-8:Protein Trafficking/ Transport/ Translocation, Assembly

303, 3F,BICC

11:10-12:10

S1-9:Protein Splicing and Endo-and Exocytosis

08:30-12:10

S3-6:Protein Therapeutics for Immunologic & Inflammatory Diseases

305A, 3F,BICC

08:30-10:50

S5-7:Bacterial Protein Kinases

310, 3F,BICC

10:50-11:30

S5-8:The AKT/PI 3-Kinases, and The MAP Kinase Pathway

11:30-12:20

S5-9:Protein Kinases as Targets for Metabolic Disease

08:30-12:10

S6-7:  New Peptides Drug Discovery

311A, 3F,BICC

08:30- 10:50

S8-1:Protein Biomarker Discovery and Validation for Diagnosis and Treatment

311B, 3F,BICC

10:50-12:30

S8-2:Toxicity Biomarkers and Biomarkers Assay Development

08:30-10:30

S10-3:HPLC, LC-MS and SFC in Protein Analysis

311C, 3F,BICC

10:30-12:10

S10-4:Spectroscopic Analysis and other GMP Compliance Analytical Methods

08:30-12:10

S 12-1:Proteins as Drugs-Non-Antibody and Non-Vaccine Protein Therapeutics

306, 3F,BICC

March 23, 2010

12:00-13:00

Luncheon

Banquet Hall, 2F, BCGH

Afternoon
March 23, 2010

13:30-17:30

S1-10:Protein Modifications and Metabolism

301, 3F,BICC

13:30-17:30

S1-11:Intrinsically Disordered Porteins

302, 3F,BICC

13:30-17:30

S1-12:Structure Biology, Protein Structure, Dynamics and Functions(Part II))

303, 3F,BICC

13:30-15:50

S4-5 : Proteomics of Lung Cancer, Esophageal Cancer, Leukemia, Ovarian and Cervical Cancer

305A, 3F,BICC

15:50-18:10

S4-6:Proteomics of Hepatic and Pancreatic Cancer

13:30-14:45

S5-10:Wnt / Hedgehog / Notch Signaling Pathways

310, 3F,BICC

14:45-17:30

S5-11:Kinase Screening, Profiling, Identification and Lead Optimization

13:30-15:30

S5-12:Small Molecule Kinase Inhibitor Discovery

311A, 3F,BICC

15:30-17:30

S5-13:Translation Regulation in the CNS

13:30-15:10

S8-3:Protein Biomarkers for Cancers

311B, 3F,BICC

15:30-17:10

S8-4:Protein Biomarkers for Diseases: Cardiovascular, CNS, Inflammation and Immunology

17:10-17:50

S8-5:Biomarker for Personalized Medicine

13:30-14:15

Workshop 1 311C, 3F,BICC

14:20-17:30

 Young Scientists Forum

311C, 3F,BICC

March 23, 2010

18:00-19:00

Dinner

Banquet Hall, 2F, BCGH

March 21-23, 2010

08:30-17:30

Exhibition and Posters

3F,BICC

March 24-25, 2010

 

Tour in Beijing

 

March 26-27, 2010

 

Tour in Xi’an

 


© 2008-2010 All right reserved for BIT Conferences
Contact Us: Tel: 0086-411-84799609, Fax: 0086-411-84799629